Pharma Focus Asia

Astellas Pharma Set to Unveil State-of-the-Art Life Sciences Facility in Massachusetts, USA


Astellas Pharma opens a new state-of-the-art life sciences facility to expand its R&D footprint in order to accelerate innovation and deliver VALUE to patients.


The new facility is set to utilise two floors encompassing approximately covering 62,000 square feet.

This facility will accommodate both laboratory and office spaces to house the discovery accelerator.

The facility will become the operational hub for several diverse functions including medical & development, business development, and research.

This investment stands as a testament to enduring growth in the Greater Boston vicinity, as well as its endeavour to foster novel centres of innovation and synergy.

The forthcoming establishment will foster a harmonious environment, facilitating seamless collaboration to harness the wide-ranging expertise both within the organisation and beyond its confines.

The upcoming facility is anticipated to open in 2024.


Name Astellas Pharma
Type New Construction
Year 2024

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Adopting the Power of AI to Drug Development ProjectsROUQETTE - Pharma Virtual LabDUPHAT 2024Asia Healthcare Week 20247th Annual Pharma Project & Portfolio Management 2024CHEMICAL INDONESIA 2024INALAB 2024The Drug Safety Symposium 2024